SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2(a)

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Explanatory Note

This Amendment No. 1 (this “Amendment”) amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on November 12, 2019 (the “Schedule 13D”), by the Reporting Persons relating to the common stock, par value $0.001 (the “Common Stock”), of Sonim Technologies, Inc., a Delaware corporation (the “Issuer”).

Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment. Capitalized terms used but not defined in this Amendment have the respective meanings set forth in the Schedule 13D. All references in the Schedule 13D and this Amendment to the “Statement” will be deemed to refer to the Schedule 13D as amended and supplemented by this Amendment.      

Item 3 is amended to add the following:

Since the filing of the Schedule 13D on November 12, 2019, the following Reporting Persons have acquired shares of Common Stock as follows:

See Item 4 below for additional information.

Item 4 is hereby amended to add the following:  

On June 1, 2020, BRPI entered into a Note Amendment and Debt Cancellation Agreement (the “Debt Cancellation Agreement”) with the Issuer which amended the Convertible Promissory Note to provide that, contingent upon the closing of the Offering, the Company would repay $4,000,000 of the outstanding indebtedness to BRPI in cash, and the remaining principal amount, accrued interest and other amounts outstanding under the Convertible Promissory Note would convert into shares of Common Stock at the public offering price of shares in the Offering. On June 4, 2020, BRPI sold to BRPLP an interest in the Convertible Promissory Note for $3,500,000. On June 9, 2020, the Issuer completed the Public Offering at a price per share of Common Stock of $0.75. As a result, on June 9, 2020, pursuant to the Debt Cancellation Agreement, the Company paid to BRPI $4,000,000 and the remaining principal amount, accrued interest and other amounts outstanding under the Convertible Promissory Note converted into an aggregate of 8,226,834 shares of Common Stock issued to BRPI and BRPLP (the “Conversion Shares”).  

On June 11, 2020, the Issuer, BRPI and BRPLP entered into a registration rights agreement (the “RRA”) pursuant to which the Issuer agreed to prepare and file a registration statement (the “Resale Registration Statement”) with the Securities and Exchange Commission (the “SEC”) for the resale of the Conversion Shares within 30 days of the closing of the Offering, and to use best efforts to have the Resale Registration Statement declared effective by the earliest of (i) if the Resale Registration Statement does not become subject to review by the SEC, 60 days after such closing, or (ii) if the Resale Registration Statement becomes subject to review by the SEC, 150 days after such closing, or longer if the SEC has not declared the Resale Registration Statement effective despite the Issuer’s best efforts. The RRA provides for liquidated damages upon the occurrence of certain events including the failure by the Issuer to file the Resale Registration Statement or cause it to become effective by the deadlines set forth above.  

The foregoing descriptions of the Debt Cancellation Agreement and the RRA do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the Debt Cancellation Agreement and the RRA, which are filed as Exhibits 4 and 5 hereto, respectively, and are incorporated herein by reference.

Paragraphs (a) and (b) of Item 5 are amended and restated in their entirety as follows:  

(a) – (b)  

1. As of the date hereof, BRF beneficially owns directly 1,139,085 shares of Common Stock representing 1.7% of the Issuer’s Common Stock, BRPLP beneficially owns directly 7,120,325 shares of Common Stock, representing 10.8% of the Issuer’s Common Stock, BRPI beneficially owns directly 3,560,167 shares of Common Stock, representing 5.4% of the Issuer’s Common Stock, and Mr. Riley beneficially owns 12,639,577 shares of Common Stock representing 19.2% of the Issuer’s Common Stock either in his capacity as custodian for his children or as trustee of the Robert Antin Children Irrevocable Trust.

2. BRPGP is the general partner of BRPLP, BRCM is the parent company of BRPGP and BRF is the parent company of BRCM. As a result, BRPGP, BRCM and BRF may be deemed to indirectly beneficially own the Common Stock held by BRPLP.    

3. Mr. Riley is the Chief Executive Officer of BRCM and Chairman and Co-Chief Executive Officer of BRF. As a result, Mr. Riley may be deemed to indirectly beneficially own the Shares held by BRF, BRPI and BRPLP.  

Each of the Reporting Persons may be deemed a member of a “group” with the other Reporting Persons for purposes of Rule 13d-5(b)(1) of the Exchange Act, and thus, may be deemed to beneficially own the securities of the Issuer owned by the other Reporting Persons. The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Exchange Act, the beneficial owners of any securities of the Issuer it does not directly own or control. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that it does not directly own or control.  

As of the date hereof, each of BRPLP, BRPGP, BRCM, BRF and Mr. Riley may be deemed to have shared power to vote or direct the vote of, and to dispose or direct the disposition of, the Shares beneficially owned directly by BRPLP.  

As of the date hereof, each of BRPI, BRF and Mr. Riley may be deemed to have shared power to vote or direct the vote of, and to dispose or direct the disposition of, the Shares beneficially owned directly by BRPI.  

As of the date hereof, each of BRF and Mr. Riley may be deemed to have shared power to vote or direct the vote of, and to dispose or direct the disposition of, the Shares beneficially owned directly by BRF.           

Item 6 is amended to add the following: The descriptions of the Debt Cancellation Agreement and the RRA included in Item 4 are incorporated into this Item 6 by reference.    

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: June 29, 2020

 EXHIBIT 1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, $0.001 par value per share, of Sonim Technologies, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Date: November 11, 2019

SCHEDULE A

Executive Officers and Directors of B. Riley Financial, Inc.

13